tiprankstipranks
Trending News
More News >
Yield10 Bioscience (YTENQ)
OTHER OTC:YTENQ
US Market

Yield10 Bioscience (YTENQ) Income Statement

Compare
333 Followers

Yield10 Bioscience Income Statement

Last quarter (Q2 2024), Yield10 Bioscience's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Yield10 Bioscience's net income was $-3.24M. See Yield10 Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 60.00K$ -7.30M$ 6.82M$ 6.16M$ -4.04M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ -263.00K$ 220.00K$ 182.00K$ -203.00K
EBITDA
$ -14.16M$ -13.15M$ -11.47M$ -9.43M$ -13.01M
Operating Income
$ -14.42M$ -13.45M$ -11.69M$ -9.61M$ -8.60M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -14.46M$ -13.57M$ -11.03M$ -10.21M$ -12.96M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Yield10 Bioscience Earnings and Revenue History